Katayama Y, Kashiwagi F, Memezawa H, Terashi A
Second Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Jpn Circ J. 1992 Dec;56(12):1239-47. doi: 10.1253/jcj.56.1239.
A PGI2 derivative, OP-41483, and a hyperosmotic agent, glycerol, were tested for possible beneficial effects on brain edema, metabolism and pathological changes in cerebral ischemia. Combination treatment with these agents was also tested. Cerebral ischemia was produced in spontaneously hypertensive rats, using bilateral common carotid artery ligation (BLCL). OP-41483 was administered four times, hourly (500 ng/kg x 4, i.p.). Ten percent glycerol was administered intravenously (6.6 ml/kg). And, for the combination treatment, OP-41483 was administered three times, hourly (500 ng/kg x 3, i.p.), and 10% glycerol was administered intravenously (6.6 ml/kg) in the same manner as the glycerol treated group. In ischemic controls, saline was administered intravenously (6.6 ml/kg). After 3 h of ischemia, brain water content and metabolites were determined and pathological observation was conducted using electron microscopy. OP-41483 treated animals maintained higher levels of ATP concentration and reduced accumulation of lactate, but showed no difference in brain water content compared to saline treated controls. Glycerol treated animals showed significance in terms of reduction of brain water content and accumulation of lactate. Glycerol abated the depletion of ATP concentration. OP-41483+glycerol treated animals showed the most significant effect on the reduction of brain water content and accumulation of lactate. The combination treatment also maintained higher levels of ATP concentration. Additionally, swelling of astrocytic foot processes and mitochondria with destroyed crista were not observed pathologically in the combination treated animals. These results show that OP-41483, glycerol and combination treatment are beneficial in the treatment of cerebral ischemia. They also indicate that the combination treatment significantly enhances the protective effects compared to individual treatment.
一种前列环素(PGI2)衍生物OP - 41483和一种高渗剂甘油,被测试用于观察其对脑缺血后脑水肿、代谢及病理变化是否可能具有有益作用。同时也测试了这两种药物的联合治疗效果。通过双侧颈总动脉结扎(BLCL)在自发性高血压大鼠中诱导脑缺血。OP - 41483每小时给药一次,共给药四次(500 ng/kg×4,腹腔注射)。10%的甘油静脉给药(6.6 ml/kg)。对于联合治疗,OP - 41483每小时给药三次(500 ng/kg×3,腹腔注射),10%甘油以与甘油治疗组相同的方式静脉给药(6.6 ml/kg)。在缺血对照组中,静脉注射生理盐水(6.6 ml/kg)。缺血3小时后,测定脑含水量和代谢物,并使用电子显微镜进行病理观察。OP - 41483治疗的动物维持较高的ATP浓度水平,乳酸积累减少,但与生理盐水治疗的对照组相比,脑含水量无差异。甘油治疗的动物在脑含水量降低和乳酸积累方面具有显著效果。甘油减轻了ATP浓度的消耗。OP - 41483 +甘油治疗的动物在降低脑含水量和乳酸积累方面显示出最显著的效果。联合治疗也维持了较高的ATP浓度水平。此外,联合治疗的动物在病理上未观察到星形胶质细胞足突肿胀和线粒体嵴破坏。这些结果表明,OP - 41483、甘油及联合治疗对脑缺血治疗有益。它们还表明,与单独治疗相比,联合治疗显著增强了保护作用。